Nothing Special   »   [go: up one dir, main page]

Muzaffar et al., 1972 - Google Patents

Studies on fibrin formation and effects of dextran

Muzaffar et al., 1972

Document ID
13418144064603019672
Author
Muzaffar T
Youngson G
Bryce W
Dhall D
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

In this study highly reproducible turbidimetric techniques are used to investigate clotting of human platelet-poor plasma and purified human fibrinogen solutions by thrombin. Three phases are clearly distinguishable turbidimetrically during clotting. All the three phases are …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Latallo et al. Inhibition of fibrin polymerization by fibrinogen proteolysis products
Muzaffar et al. Studies on fibrin formation and effects of dextran
Alkjaersig et al. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization
Bale et al. Effects of thrombospondin on fibrin polymerization and structure.
Godal et al. Gelation of soluble fibrin in plasma by ethanol
Edsall et al. Chemical, clinical, and immunological studies on the products of human plasma fractionation. XV. The proteins concerned in the blood coagulation mechanism
US4011045A (en) Turbidity reduction in triglyceride standards
Biggs et al. The action of thromboplastic substances
US4416812A (en) Method of preparing tissue thromboplastin
US3179567A (en) Reagent and method for determining the coagulability of blood
Wilner et al. Aggregation of platelets by collagen: polar active sites of insoluble human collagen
Niléhn et al. Plasma Prothrombin during Treatment with Dicumarol: I. Immunochemical Determination of its Concentration in Plasma
JP3180824B2 (en) Blood coagulation reagent
Wilf et al. Acceleration of fibrin gel formation by unrelated proteins
Nanninga et al. Preparation and properties of anticoagulant split product of fibrinogen and its determination in plasma
Blumberg et al. Further evidence on the protein complexes of some hyaluronic acids
EP0003474A1 (en) Method for the determination of prothrombin, reagent for this determination and process for preparing a factor Xa preparation
Smith et al. Possible mechanisms for the increase in alkaline phosphatase activity of lyophilized control material
Silberman et al. Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity
Teger-Nilsson et al. Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogen
Sultan et al. Immunologie Studies in von Willebrand’s Disease
US3993585A (en) Elevated human lipids control
Ito et al. Isozymes of bovine milk catalase
Kirchmaier et al. A hemostasis activating factor (HAF) in subcutaneous tissue extracts: Effects on morphologic platelet changes, platelet retention and platelet aggregation
JP3180825B2 (en) Blood coagulation measurement method